Research output per year
Research output per year
Organization profile
Organization profile
Our mission at the Fox Chase - Temple Urologic Institute is to lead the way in urologic care, education, and research across the Delaware Valley and beyond. We are committed to expanding access to advanced urologic care for patients across the region, integrating urology across the Temple Health system under the banner of Fox Chase-Temple Health Urologic Institute, attracting top talent to our premier fellowships and growing the Temple Urology residency. At the heart of our mission is a commitment to research excellence, through building a dynamic research portfolio that opens new trials, obtains grant support, and maintains some of the largest clinical databases in the world. The Temple Urologic Institute is lead by Alexander Kutikov, MD.
Fingerprint
Dive into the research topics where Fox Chase - Temple Urologic Institute is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial
George, A. K., Miocinovic, R., Patel, A. R., Lomas, D. J., Correa, A. F., Chen, D. Y. T., Rastinehad, A. R., Schwartz, M. J., Uchio, E. M., Sidana, A., Helfand, B. T., Gahan, J. C., Yu, A., Vourganti, S., Barqawi, A. B., Brisbane, W. G., Wysock, J. S., Polascik, T. J., McClure, T. D. & Coleman, J. A., Jun 2024, In: Cancers. 16, 12, 2178.Research output: Contribution to journal › Article › peer-review
-
Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010
Karam, J. A., Uzzo, R., Bex, A., Leung, W., Tat, C., Nicholas, A., Andreev-Drakhlin, A., Huseni, M., Pal, S. K. & Master, V. A., Jul 1 2024, (Accepted/In press) In: EUROPEAN UROLOGY ONCOLOGY.Research output: Contribution to journal › Article › peer-review
-
Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial
Lara, P. N., Tangen, C., Heath, E. I., Gulati, S., Stein, M. N., Meng, M., Alva, A. S., Pal, S. K., Puzanov, I., Clark, J. I., Choueiri, T. K., Agarwal, N., Uzzo, R., Haas, N. B., Synold, T. W., Plets, M., Vaishampayan, U. N., Shuch, B. M., Lerner, S. & Thompson, I. M. & 1 others, , Sep 2024, In: European Urology. 86, 3, p. 258-264 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Prizes
-
-
-
G. Willing "Wing" Pepper Chair in Cancer Research
Uzzo, R. G. (Recipient), 2008
Prize: Other distinction
Press/Media
-
New Findings from Case Western Reserve University School of Medicine in the Area of Bladder Cancer Described (Identification and Validation of Prognostic Model for Tumor Microenvironment-associated Genes In Bladder Cancer Based On Single-cell ...)
Plimack, E. R., Kutikov, A., Uzzo, R. G. & Abbosh, P.
09/16/24
1 item of Media coverage
Press/Media
-
Dr. Sanjay S. Reddy Receives Faculty Citizenship Award From Fox Chase Cancer Center
08/14/24
1 item of Media coverage
Press/Media